Fondaparinux Sodium Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 2.5 mg/0.5 mL, 5 mg/0.4 mL, 7.5 mg/0.6 mL, 10 mg/0.8 mL
Reference Brands: Arixtra (USA)
Category: Critical Care
Fondaparinux is a synthetic anticoagulant that inhibits factor Xa, an essential enzyme in the blood clotting process. It is used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE) and to prevent blood clots after major orthopedic or abdominal surgery. Fondaparinux sodium is available in Injection and strengths such as 2.5 mg/0.5 mL, 5 mg/0.4 mL, 7.5 mg/0.6 mL, 10 mg/0.8 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fondaparinux sodium is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Fondaparinux sodium can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Fondaparinux sodium is used to prevent and treat blood clots in conditions such as deep vein thrombosis and pulmonary embolism, particularly after orthopedic or abdominal surgery.
Fondaparinux sodium is made from a synthetic pentasaccharide that selectively inhibits activated Factor Xa, preventing clot formation.
Trade names include Arixtra and Idraparinux (investigational).
Fondaparinux sodium is manufactured by Aspen Pharmacare, Mylan, and originally developed by GlaxoSmithKline under the brand name Arixtra.
The generic name is Fondaparinux sodium.
The brand name is Arixtra.
Fondaparinux sodium is manufactured in countries such as the United States, India, and the United Kingdom by several pharmaceutical companies for both hospital and retail use.
Related Products
Methimazole
Strength:
5 mg, 10 mg
Form: Tablets
Reference Brands: Tapazole (USA), Northyx (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
